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OVER the last 6 years, intestinal transplantation has become a feasible therapeutic option for patients 
with irreversible intestinal failure.! However, it has never 
been elucidated whether donor factors affect the recipient 
outcome. In this study we analyzed the influence of donor 
criteria on early outcome after intestinal transplantation. 
MATERIALS AND METHODS 
From May 1990 to September 1995. a total of 72 patients received 
77 intestinal grafts (27 isolated intestine, 36 liver and intestinal, and 
14 multivisceral) at our center. Donors ranged from newborn to 
age 48 years. Fifty-one donors were male, and 26 were female. The 
most common causes of death were motor-vehicle accidents, 
cerebrovascular accidents. and gunshot wounds. Length of hospital 
stay for the donors was 1 to 21 days. Ten of 77 donors had 
cardiopulmonary resuscitation, and 18 were maintained on high 
vasopressor (either higher than 10 J.Lg/kg per minute of dopamine, 
norepinephrine and/or epinephrine) during the donor operation. A 
total of 2 to 4 L (50 to 100 mL/kg in children) of University of 
Wisconsin (UW) solution was used for in situ perfusion in the 
donor operation. Cold ischemia time (CIT) ranged from 2.8 to 17 
hours, with a mean of 7.7 hours. Donor and recipient procedures 
are described elsewhere.2 Postoperative immunosuppression was 
with tacrolimus (FK 506), steroids, and in selected cases azathio-
prine (AZA). 
In an effort to predict the quality of early posttransplant graft 
function, donor variables such as age, sex, hospital stay, CPR. 
vasopressor. oxygenation (ratio of Po2/Fio2 ). sodium. creatinine. 
total bilirubin, AST, AL T, and CIT were studied. The donor 
variables were analyzed in regard to 3-month actual graft survival 
and grading of tissue damage of postperfusion intestinal specimens 
(2 to 4 hours after reperfusion) as well as posttransplant intestinal 
biopsy (within 7 days after transplantation). The grading of histol-
ogy was by Park classification on a scale of I to 8.' Multivariate 
stepwise (backward elimination method) logistic regression for 
survival and linear regression for intestinal histology were used for 
statistical analysis. 
RESULTS 
Use of high vasopressor (P = .019) and prolonged cold 
ischemia time (P = .041) significantly worsened 3-month 
survival. High donor sodium (P = .(02) significantly wors-
ened the ischemic injury on the postperfusion histology. 
Both high donor sodium (P = .(20) and use of high 
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vasopressor (P = .022) significantly worsened the ischemic 
damage on the posttransplant histology. However, grafts 
recovered within 7 days in most cases. 
DISCUSSION 
Our analysis showed that high vasopressor, prolonged cold 
ischemia time, and high sodium affect the early graft 
survival and intestinal graft injury. It is well known in liver 
transplantation that prolonged cold ischemia time deterio-
rates liver graft function and causes high incidence of 
primary nonfunction and retransplantation.4 Also, high 
sodium in donor has been recently recognized as a risk 
factor to cause early graft dysfunction in liver transplanta-
tion.s This is the first study in humans to delineate risk 
factors affecting the early graft outcome in intestinal trans-
plantation. Both proper donor management and selection 
as well as adjustment of the timing of donor and recipient 
surgery to minimize cold ischemia time are essential for the 
early success of intestinal transplantation, although the use 
of high-risk donors is sometimes inevitable owing to the 
shortage of organs and the urgent requirements of recipi-
ents. 
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